Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies999
Ariel Pharmaceuticals
Ariel Pharmaceuticals, Inc. is a biopharmaceutical company.
Sector
Subsector
Keywords
Location
Drais Pharmaceuticals
Drais Pharmaceuticals is a venture capital supported drug development company.
Sector
Subsector
Keywords
Location
total rounds
total raised
Pharmazz
Pharmazz is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for critical care medicine.
Sector
Subsector
Keywords
Location
total rounds
total raised
Egetis Therapeutics AB
Egetis is developing late-stage projects for the treatment of serious rare diseases in the orphan drug segment.
Sector
Subsector
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Ligand Pharmaceuticals
announced date
Financials
Funding Rounds1
Number of Funding Rounds
Money Raised
Their latest funding was raised on 27.07.2005. Their latest investor Balyasny Asset Management. Their latest round Venture - Series Unknown
Co-Investors
Investors10
Number of lead investors
Number of investors
Balyasny Asset Management
Balyasny Asset Management delivers consistent, uncorrelated absolute returns.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Crestview Capital
The represented VC is a North American venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Highbridge Capital Management
Highbridge Capital Management is a global alternative investment firm that offers credit and volatility focused solutions.
Sector
Subsector
Location
count Of Investments
count Of Exists
Acquisitions1
Molecular Simulations, Inc. acquired by Pharmacopeia
acquirer
date
type
Molecular Simulations, Inc.
Molecular Simulations provides molecular modeling and simulation software for research.
Sector
Subsector
Keywords
Location
People
Founders2
Larry Bock
Larry Bock is the founder and organizer of the USA Science & Engineering Festival, and a former founder of the San Diego Science Festival. Mr. Bock is a Special Limited Partner to Lux Capital, a $100M nanotechnology-focused venture capital fund. He is a member of the Board of Directors of FEI Corporation (NASDAQ: FEIC), the leading supplier of tools for nanotechnology research. He is a General Partner of CW Ventures, a $100M life sciences venture capital fund. Mr. Bock was the founder and former executive chairman and initial CEO of Nanosys and the founder and initial CEO of Neurocrine Biosciences (NASDAQ: NBIX), Pharmacopeia (NASDAQ: PCOP), GenPharm International, which was acquired by Medarex for $100 million; Caliper Technologies (NASDAQ: CALP); Illumina Technologies (NASDAQ: ILMN), among numerous other firms. He was also a seed or early-stage investor in variety of firms, including Acceleron Pharma, Aurora Biosciences, Biosym Technologies, ekoVenture. Gen-Probe, Gensia Pharmaceuticals, Genocea Biosciences, IDEC Pharmaceuticals Magen Biosciences, Oclassen Pharmaceuticals Plexikon Pharmaceuticals, Poland Partners, Sequana Therapeutics, Sapphire Energy, Siluria, Sirtris Pharmaceuticals, Software Transformation, and Viagene. Mr. Bock started his career as a researcher in the early days at Genentech, the field of infectious diseases, where he was on the team that received the AAAS Newcomb Cleveland Prize for demonstrating the world’s first recombinant DNA vaccine. He was a Venture Capital Associate with Fairfield Ventures (now Oxford Bioventures). Larry and his wife, Diane, established the Larry and Diane Bock Chair in Nanotechnology at the University of California, Berkeley. They also founded Community Cousins, a non-profit foundation focused on breaking down racial barriers, that was selected by former Vice President Al Gore as one of 10 outstanding grass root efforts nationally. Larry is organizing the San Diego Science Festival with BioBridge of UCSD. He works extensively with the Sudanese and Burmese refugee’s networks in San Diego and is a tutor in math and sciences for Sudanese refugee children in St. Lukes Sudanese Refugee Network and a Mentor for Burmese refugee families through Jewish Family Services. Larry received his B.A. in Biochemistry (summa cum laude) from Bowdoin College and his M.B.A. from the Anderson School at UCLA.
current job
count Of Investments
count Of Exists
Larry Bock
John J. Baldwin
John Baldwin is the Co-Founder of iVIEW Therapeutics. John previously worked at Vitae Pharmaceuticals as a President. He attended the Univ. of Delaware and Univ. of Minnesota.
current job
organization founded
John J. Baldwin
Employee Profiles9
John J. Baldwin
Co-Founder and Chief Scientific and Technology Officer
Rene Belder
Senior Vice President of Clinical Development
Maria L. Webb
Vice President of Preclinical Research
Arthur Roke
Chief Accounting Officer & VP of Finance